Please turn JavaScript on
NanoApps Medical – Official website icon

NanoApps Medical – Official website

Want to stay in touch with the latest updates from NanoApps Medical – Official website? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: NanoApps Medical – Official website – NanoApps Medical – Official website

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.75 / day

Message History

Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created by lost brain tissue into a more favorable environment for healing. The treatment recruited the body's own immune cells, encouraged [...]

Read full story
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. Researchers at Washington University School of Medicine in St. Louis have now identified lymph node-like structures inside the skull bone marrow of [...]

Read full story
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to the lungs. The study, led by Jingan Chen and colleagues, found that the treatment restored production of functional cystic fibrosis [...]

Read full story
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of death by 60% in phase 3 trials. Patients who received the medication in trials lived 13.2 months, compared with those [...]

Read full story
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often responds poorly to standard pain medications. Researchers at The University of Texas MD Anderson Cancer Center now report evidence that [...]

Read full story